10 July 2020 - - US-based pharmaceutical company scPharmaceuticals Inc. (NASDAQ: SCPH) has appointed Sara Bonstein to its board of directors, the company said.

Bonstein fills the vacancy created from Dorothy Coleman's resignation from the board of directors. Coleman stepped down from the board after serving since April 2015.

Bonstein has over 15 years of operational and financial leadership experience in the life sciences industry.

She currently holds the position of chief financial officer of Insmed Inc., a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases.

Previously, Bonstein has served as chief financial officer, chief operating officer and corporate secretary at OncoSec Medical and as the chief financial officer, secretary, treasurer, and executive vice president at Advaxis, Inc.

Prior to these roles, Bonstein held several roles at Eli Lilly and company and Johnson and Johnson. Bonstein holds a BS in Finance from The College of New Jersey and an MBA from Rider University.

scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes.

The company's lead programmes focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA.